Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boehringer Ingelheim
Pharma
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
At a critical moment for the U.S. inhaler market, AstraZeneca is following its peer Boehringer Ingelheim and taking a step to boost patient access.
Fraiser Kansteiner
Mar 18, 2024 11:02am
Boehringer cuts out-of-pocket inhaler prices to $35 in US
Mar 7, 2024 11:10am
Boehringer Ingelheim pledges €120M to expand Greek pharma plant
Jan 12, 2024 9:14am
Theravance's COPD med Yupelri flunks head-to-head study
Jan 5, 2024 10:14am
Big Pharma deal spree, China plans and more—Fierce Pharma Asia
Jan 5, 2024 8:44am
Boehringer unveils new branding to convey 'unwavering optimism'
Nov 8, 2023 10:00am